| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Scott Cheryl serves as a Director at EVH and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 11 sells. Those positions are worth an estimated $448K at current prices.
Historically, Scott Cheryl's trades have earned a middling insider score of 68/100 across 8 rated trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +12.8%.
The biggest single holding is PGNY (~$448K) as Director. The recent filings there lean toward selling, a net 15,596 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | PGNY Progyny, Inc. | Director | Sale+OE | 7,439 | $26.39 | $196,278.02 | -27.3% | -2.3% | - | |
| Jun 11, 2025 | PGNY Progyny, Inc. | Director | Sell | 2,675 | $22.07 | $59,037.25 | -15.9% | +5.9% | +18.3% | |
| Jun 28, 2024 | PGNY Progyny, Inc. | Director | Sell | 1,462 | $28.39 | $41,506.18 | -12.6% | -41.6% | -23.4% | |
| Jun 27, 2023 | PGNY Progyny, Inc. | Director | Sell | 1,170 | $37.27 | $43,605.90 | -10.7% | -11.2% | -26.5% | |
| Jun 14, 2023 | EVH Evolent Health, Inc. | Director | Sell | 2,365 | $30.01 | $70,973.65 | -4.2% | -14.4% | -25.3% | |
| Nov 7, 2022 | PGNY Progyny, Inc. | Director | Sell | 850 | $40.78 | $34,663.00 | -10.5% | -17.2% | -20.7% | |
| Aug 31, 2022 | EVH Evolent Health, Inc. | Director | Sell | 3,100 | $36.76 | $113,956.00 | -5.7% | -26.6% | -30.6% | |
| Nov 8, 2021 | PGNY Progyny, Inc. | Director | Sell | 2,000 | $66.30 | $132,600.00 | -27.7% | -41.3% | -38.4% | |
| Jun 11, 2021 | EVH Evolent Health, Inc. | Director | Sell | 6,405 | $19.39 | $124,192.95 | -11.6% | +30.6% | +44.4% | |
| Jun 11, 2018 | EVH Evolent Health, Inc. | Director | Sell | 1,600 | $22.63 | $36,208.00 | -14.6% | - | - |